New

Europe Radiopharmaceuticals Market

2021

Europe Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025879 | No. of Pages: 157 | Category: Pharmaceuticals | Status: Published

Market Insights

Europe Radiopharmaceuticals Market to Grow at a CAGR of 8.5% to reach US$ 3,442.11 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Europe radiopharmaceuticals market is expected to grow from US$ 1,940.54 million in 2021 to US$ 3,442.11 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028.


The UK, Germany, France, Italy, and Spain are major economies in Europe. Rising advancements in nuclear imaging techniques is expected to fuel the market growth. The use of nuclear medicine procedures is expanding rapidly, as PET and SPECT continue to improve the accuracy of detection, localization, and characterization of disease. PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. As per the Society of Nuclear Medicine, every year, millions of nuclear medicine procedures are performed with radiopharmaceuticals and imaging instruments to diagnose disease and deliver targeted treatments in the countries across the region. These techniques have also been adopted in immunology, infection, gastroenterology, cardiology, oncology, neurology, and psychiatry, among other fields, for diagnosis and other applications. Advanced nuclear medicines and modern imaging equipment are assisting doctors in diagnosing diseases in a better manner and in less time. Continuous development of new radiopharmaceuticals for the PET/CT and SPECT/CT platforms, which are used in novel clinical applications such as neurology and orthopedics, along with the increasing accuracy of different tumor staging methods, are further contributing to the market growth. In September 2020, Curium launched Detectnet, a positron emission tomography (PET) agent, indicated for the localization of somatostatin receptor-positive neuroendocrine tumors (NETs) in adult patients. Thus, the technological advancements for improving the quality and efficacy of nuclear imaging techniques are favoring the Europe radiopharmaceuticals market growth.

In case of COVID-19, Europe is highly affected especially France and Russia. The COVID-19 pandemic has profoundly changed hospital activities, including NM practice across Europe. A literature search on PubMed was performed covering COVID-19 studies published up until January 2021. As per the findings, the pandemic strongly challenged NM departments, and a reduction in the workforce has been experienced in every center in Europe. NM departments introduced restriction measures to limit COVID-19 transmission, including rescheduling of non-high-priority procedures. Also, some of the departments experienced a delay in radiopharmaceuticals supply or technical assistance due to COVID-19. As a result, the pandemic resulted in a significant reduction of diagnostic and therapeutic NM procedures and a reduced level of care for patients affected by diseases other than COVID-19, such as cancer or acute cardiovascular disease. The pandemic influenced workflows in a substantial proportion of NM departments. New findings supporting COVID-19 diagnosis are expected to accelerate the growth of radiopharmaceuticals in the region. For instance, as per the research study by Chentao Jin et al., published in the European Journal of Nuclear Medicine and Molecular Imaging in May 2021, positron emission tomography (PET) is expected to offer pathophysiological alternations of COVID-19 and facilitate the clinical management of patients. With the role of PET in the COVID-19, the research studies can also pave the way in combating other epidemics in the future.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe radiopharmaceuticals market. The Europe radiopharmaceuticals market is expected to grow at a good CAGR during the forecast period.
Europe radiopharmaceuticals market

Get more information on this report :


Europe Radiopharmaceuticals Market Segmentation

Europe Radiopharmaceuticals Market – By Type

  • Diagnostic Nuclear Medicine
    • SPECT
    • PET
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
    • Beta Emitters
    • Brachytherapy Isotopes

Europe Radiopharmaceuticals Market – By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

Europe Radiopharmaceuticals Market – By End User

  • Hospitals
  • Imaging Centers
  • Academic and Research Centers
  • Others

Europe Radiopharmaceuticals Market, by Country

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Europe Radiopharmaceuticals Market -Companies Mentioned

  • Advanced Accelerator Applications
  • Bayer AG
  • Bracco Imaging S.p.A
  • Cardinal Health Inc
  • Curium
  • ECZACIBAŞI MONROL NUCLEAR PRODUCTS CO.
  • GENERAL ELECTRIC
  • Lantheus Medical Imaging, Inc.
  • Nordion
  • NTP RADIOISOTOPES

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Radiopharmaceuticals Market – By Type

1.3.2 Europe Radiopharmaceuticals Market – By Application

1.3.3 Europe Radiopharmaceuticals Market – By End User

1.3.4 Europe Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2 Rising Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Availability of Alternatives

5.3 Market Opportunities

5.3.1 Escalating Growth in Emerging Countries

5.4 Future Trends

5.4.1 Suring Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– Europe Analysis

6.1 Europe Radiopharmaceuticals Market Revenue Forecast and Analysis

7. Europe Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 Europe Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 Europe Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 Europe Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Radiopharmaceuticals Market – Country Analysis

10.1 Europe: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Germany: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 Germany: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Germany: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Germany: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 Germany: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 France: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 France: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 France: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 France: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 France: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 UK: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 UK: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 UK: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 UK: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 UK: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Italy: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Italy: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Italy: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Italy: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Italy: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 Spain: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 Spain: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2 Spain: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3 Spain: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 Spain: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3 Rest of Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on Europe Radiopharmaceuticals Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Nordion

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 NTP RADIOISOTOPES

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Advanced Accelerator Applications

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Germany Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Germany: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. Germany: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. France: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8. France Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. France Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. France: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. France: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. UK: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13. UK Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. UK Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. UK: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. UK: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Italy: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Italy Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Italy Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Italy: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Italy: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. Spain: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Spain Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. Spain Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. Spain: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. Spain: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of Europe: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of Europe: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Radiopharmaceuticals Market Segmentation

Figure 2. Europe Radiopharmaceuticals Market Segmentation, By Country

Figure 3. Europe Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe PEST Analysis

Figure 7. Europe Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. Europe Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. Europe Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. Europe Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Europe SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. Europe Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. Europe Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Europe Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in European Country Markets

  1. Advanced Accelerator Applications
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. Cardinal Health Inc
  5. Curium
  6. ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
  7. GENERAL ELECTRIC
  8. Lantheus Medical Imaging, Inc.
  9. Nordion
  10. NTP RADIOISOTOPES  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radiopharmaceuticals market.       
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it 
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025879
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.